Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS

NCT: NCT04870255 · RECRUITING

NCT IDNCT04870255
StatusRECRUITING
Start Date2021-07-20
Completion2026-12
SponsorStanford University (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) or bipolar II disorder in a current mood depressive episode (MDE).

Frequently Asked Questions

What is Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS?

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS is a clinical trial registered under NCT04870255. Current status: RECRUITING.

What is the status of NCT04870255?

The current status of NCT04870255 (Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS) is: RECRUITING.

When did Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS start?

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS started on 2021-07-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑